Common Variation in the NOS1AP Gene Is Associated With Drug-Induced QT Prolongation and Ventricular Arrhythmia-Reference-Cited by-同舟云学术

Common Variation in the NOS1AP Gene Is Associated With Drug-Induced QT Prolongation and Ventricular Arrhythmia

Published:2012-08 Issue:9 Volume:60 Page:841-850
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Jamshidi Yalda,Nolte Ilja M.,Dalageorgou Chrysoula,Zheng Dongling,Johnson Toby,Bastiaenen Rachel,Ruddy Suzanne,Talbott Daniel,Norris Kris J.,Snieder Harold,George Alfred L.,Marshall Vanessa,Shakir Saad,Kannankeril Prince J.,Munroe Patricia B.,Camm A. John,Jeffery Steve,Roden Dan M.,Behr Elijah R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Rhythm control agents and adverse events in patients with atrial fibrillation;Taylor;Int J Clin Pract,2010

2. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits;Camm;Int J Cardiol,2012

3. Torsade de pointes induced by short-term oral amiodarone therapy;Lim;Europace,2006

4. Amiodarone: pharmacology, clinical actions and relationships between them;Nattel;J Cardiovasc Electrophysiol,1992

5. Classification of anti-arrhythmic drugs;Vaughan-Williams,1970

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic variants and effect modifiers of QT interval prolongation in patients with sickle cell disease;Gene;2024-01

2. Pharmacogenomics in cardiovascular disease;Diagnostic Molecular Pathology;2024

3. Inherited channelopathies and acquired phenocopies;Genomic and Molecular Cardiovascular Medicine;2024

4. Pharmacogenomics of Cardiovascular Diseases: The Path to Precision Therapy;Pharmacogenomics and Pharmacogenetics in Drug Therapy [Working Title];2023-10-14

5. Multifactorial model for prediction of the development of polymorphic ventricular tachycardia in patients with drug-induced QT interval prolongation induced by class III antiarrhythmic drugs;Journal of Arrhythmology;2023-07-17